Is LRCX a good stock to buy?
Lam Research Corporation · end-of-day data as of Nov 13, 2026
- PT$358.50 +58.7%
- ConsensusBuy · 34
- P/E vs own-28.8%
- MACD2.53
- Earnings in75d
- P/E33.7x
- RSI42
- Support-11.8%
- Resistance+10.7%
- Off 52w high-48.5%
- Volume0.8x
- Bollingerlower half
- News
- FCF yield+2.3%
- Sector→ -15.8%
- 52w range$136–$439
- ATR+7.3%
- Off ATH-48.5%
- P/E vs sector+14.4%
- Insiders-$38.81M
- Trendbearish
- MAs0 of 4
Updates with the 15-min delayed price. Not a forecast or investment advice.
Is Lam Research a good stock to buy?
Lam Research is strong on 4 of the 5 questions about the business; weak on fragility. The price is about usual: 33.7 times its earnings, near its 3-year median of 32.9 (Nov 13, 2026). pretickt does not say whether to buy or sell.
- Demand growing
- Advantage hard to copy
- Economics very profitable
- Execution delivers
- Fragility fragile
- Price about usual
LRCX sales growth revenue growth
+10%a year, for the last 3 yearsLam Research's sales grew 10% a year for 3 years, to $23.23B in fiscal 2026.
LRCX analysts' forecast revenue estimates
+52%the sales they expect next fiscal year, on the lastAnalysts expect Lam Research's sales to grow 52% to $35.36B in fiscal 2027 (24 analysts).
LRCX competitors
pretickt analysis+33%its sales in 12 months, on a year before
Lam Research's sales grew 33% in the 12 months to Sep 27, 2026, faster than Arm (+24%), Texas Instruments (+20%) and Intel (+12%).
LRCX sales by business revenue by segment
64%of its sales from SystemSystem brought Lam Research 64% of its sales in fiscal 2026; Customer Support and Other 36%.
LRCX return on capital ROIC
pretickt analysis95%earned before tax on the money invested in it
Lam Research earned 95% before tax on the capital invested in it in the 12 months to Sep 27, 2026; Applied Materials 44%, Texas Instruments 30%, Arm 15% and Intel 1%.
LRCX margin on each sale gross margin
51%left after making the productLam Research kept 51% of each sale after making the product in the 12 months to Sep 27, 2026; its competitors' median is 55%.
LRCX margin after costs profit margin
37%of sales left after running the businessLam Research's operating margin was 37% in the 12 months to Sep 27, 2026, against 30% in fiscal 2023.
LRCX cash generated free cash flow
$6.54Bcash left after investing, last 12 monthsLam Research generated $6.54B of free cash flow in the 12 months to Sep 27, 2026, less than its reported profit.
LRCX earnings vs estimates
8 of 8quarters above the analysts' estimateLam Research beat the analysts' profit estimate in each of its last 8 quarters, the latest on Oct 21, 2026.
LRCX insider selling
-$168Msold, net, by its executives in 12 monthsLam Research's executives and directors sold a net $168M of shares in the 12 months to Nov 13, 2026; none bought.
LRCX number of employees
+23%more people in a yearLam Research had 23,300 employees at the end of fiscal 2026, 23% more than a year before.
LRCX CEO pay
$40.35Mfor fiscal 2026, 83% of it in stock and optionsLam Research paid its CEO $40.35M for fiscal 2026, 83% of it in stock and options.
LRCX financial health Altman Z-score
18.8Altman Z-score, safe above 3Lam Research's Altman Z-score is 18.8 (Nov 13, 2026), above 3, where the safe zone starts.
LRCX biggest customers
55%of sales from its 4 biggest customersFour customers, unnamed in Lam Research's 10-K, made 55% of its sales in fiscal 2026.
LRCX in past recessions
pretickt analysis-55%its sales in the worst oneLam Research's sales fell in 1 of the last 2 US recessions, by as much as 55% in fiscal 2009.
LRCX price vs profit P/E ratio
33.7×a year's earningsLam Research's P/E ratio is 33.7 (Nov 13, 2026), near its 3-year median of 32.9.
LRCX price vs competitors
pretickt analysis33.7×a year's earnings, against its competitorsInvestors pay 33.7 times Lam Research's earnings (Nov 13, 2026), more than for Applied Materials (29.4), less than for Arm (219.0) and Texas Instruments (39.3).
LRCX analysts' target price target
+59%to their average targetAnalysts' average price target for Lam Research is $359, 59% above the Nov 13, 2026 close of $225.92.
LRCX growth priced in fair value
pretickt analysis+17%a year, for ten years, to be worth the priceAt $225.92 a share, Lam Research's free cash flow must grow about 17% a year for ten years to be worth the price (Nov 13, 2026).
What is Lam Research's P/E ratio?
Lam Research's P/E ratio is 33.7 (Nov 13, 2026), near its 3-year median of 32.9. Investors pay 33.7 times Lam Research's earnings (Nov 13, 2026), more than for Applied Materials (29.4), less than for Arm (219.0) and Texas Instruments (39.3).
Who are Lam Research's biggest competitors?
pretickt compares Lam Research with Texas Instruments, Applied Materials, Intel and Arm. Lam Research's sales grew 33% in the 12 months to Sep 27, 2026, faster than Arm (+24%), Texas Instruments (+20%) and Intel (+12%).
Is Lam Research profitable?
Lam Research's operating margin was 37% in the 12 months to Sep 27, 2026, against 30% in fiscal 2023. Lam Research generated $6.54B of free cash flow in the 12 months to Sep 27, 2026, less than its reported profit.
Are insiders selling Lam Research stock?
Lam Research's executives and directors sold a net $168M of shares in the 12 months to Nov 13, 2026; none bought.
How does Lam Research make money?
System brought Lam Research 64% of its sales in fiscal 2026; Customer Support and Other 36%.
Who owns Lam Research stock?
3,247 institutions hold 87% of Lam Research's shares (Jun 30, 2026); Vanguard and State Street added shares that quarter, BlackRock sold some.
How many employees does Lam Research have?
Lam Research had 23,300 employees at the end of fiscal 2026, 23% more than a year before.
Who are Lam Research's biggest customers?
Four customers, unnamed in Lam Research's 10-K, made 55% of its sales in fiscal 2026.
From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.